Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2021 / N 1

Фиброзирующий саркоидоз: от понимания к перспективе лечения
А.А. Визель, Ю.Ю. Горблянский, М.М. Илькович, О.П. Баранова, Д.В. Петров, А.А. Сперанская, И.Н. Трофименко, И.Е. Тюрин, В.Д. Федотов, Е.И. Шмелёв

References

1. Ministry of Health of the Russian Federation; Russian Respiratory Society; all-Russian Pediatric Respiratory Society; Russian Scientific Medical Society of Therapists. Clinical recommendations. Sarcoidosis. ICD 10: D86. Year of approval (frequency of revision): 2019 (revision every 3 years). Moscow, 2019. 47 p. Available from: https://spulmo.ru/download/2020_klin_rek_sarkoidoz_final.pdf Accessed 2021 Oct 18 (In Russian).
2. Korsten P, Strohmayer K, Baughman RP, Sweiss NJ. Refractory pulmonary sarcoidosis – proposal of a definition and recommendations for the diagnostic and therapeutic approach. Clinical Pulmonary Medicine 2016 Mar;23(2):67-75.
3. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. British Medical Journal 1961 Nov;2(5261):1165-72.
4. Patterson KC, Hogarth K, Husain AN, Sperling AI, Niewold TB. The clinical and immunologic features of pulmonary fibrosis in sarcoidosis. Translational Research 2012 Nov;160(5):321-31.
5. Belevskiy AS, Chikina SYu. Fibrosing interstitial lung diseases (literature review). Practical Pulmonology 2020;1:60-6 (In Russian).
6. Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA 2011 Jan;357(4):391-9.
7. Rottoli P, Magi B, Perari MG, Liberatori S, Nikiforakis N, Bargagli E, Cianti R, Bini L, Pallini V. Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005 Apr;5(5):1423-30.
8. Mirsaeidi M, Banoei MM, Nienow CK, Abassi T, Hakim A, Schraufnagel D, Winston BW, Sweiss N, Baughman R, Garcia JG, Machado R. Plasma metabolomic profile in fibrosing pulmonary sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 2016;33(1):29-38.
9. Fireman E, Shahar I, Shoval S, Messer G, Dvash S, Grief J. Morphological and biochemical properties of alveolar fibroblasts in interstitial lung diseases. Lung 2001;179(2):105-17.
10. Petkova DK, Clelland CA, Ronan JE, Lewis S, Knox AJ. Reduced expression of cyclooxygenase (COX) in idiopathic pulmonary fibrosis and sarcoidosis. Histopathology 2003 Oct;43(4):381-6.
11. Khomenko AG, Erokhin VV, Filippov VP etc. Sarcoidosis as systemic granulomatosis Moscow: Medicine; 1999. 39 p. (In Russian).
12. Gharaee-Kermani M, Hu B, Phan SH, Gyetko MR. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFβ signaling and the myofibroblast. Current Medical Chemistry 2009;16(11):1400-7.
13. Xaubet A, Marin-Arguedas A, Lario S, Ancochea J, Morell F, Ruiz-Manzano J, Rodriguez-Becerra E, Rodriguez-Arias JM, Inigo P, Sanz S, Campistol JM, Mullol J, Picado C. Transforming growth factor-β1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2003;168:431-5.
14. Pabst S, Franken T, Schonau J, Stier S, Nickenig G, Meyer R, Skowasch D, Grohé C. Transforming growth factor-β gene polymorphisms in different phenotypes of sarcoidosis. The European Respiratory Journal 2011 Jul;38(1):169-75.
15. Miedema JR, Bonella F, Grunewald J, Spagnolo P. Looking into the future of sarcoidosis: what is next for treatment? Current Opinion in Pulmonary Medicine 2020 Sep;26(5):598-607.
16. Tuleta I, Biener L, Pizarro C, Nickenig G, Skowasch D. Proangiogenic and profibrotic markers in pulmonary sarcoidosis. Advances in Experimental Medicine and Biology 2018;1114:57-66.
17. Piotrowski WJ, Kiszałkiewicz J, Górski P, Antczak A, Górski W, Pastuszak-Lewandoska D, Migdalska-Sęk M, Domańska-Senderowska D, Nawrot E, Czarnecka KH, Kurmanowska Z, Brzeziańska-Lasota E. Immunoexpression of TGF-β/Smad and VEGF-A proteins in serum and BAL fluid of sarcoidosis patients. BMC Immunology 2015 Oct;16:58.
18. Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 2006;25:441-54.
19. Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM, Borok Z. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. The American Journal of Pathology 2005 May;166(5):1321-32.
20. Zissel G, Homolka J, Schlaak J, Schlaak M, Müller-Quernheim J. Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. American Journal of Respiratory and Critical Care Medicine 1996 Sep;154(3 Pt 1):713-9.
21. Hauber HP, Gholami D, Meyer A, Pforte A. Increased interleukin-13 expression in patients with sarcoidosis. Thorax 2003 Jun;58(6):519-24.
22. Jonth AC, Silveira L, Fingerlin TE, Sato H, Luby JC, Welsh KI, Rose CS, Newman LS, du Bois RM, Maier LA; ACCESS Group. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. Journal of Immunology (Baltimore, Md.: 1950) 2007 Sep;179(6):4255-62.
23. Biener L, Kruse J, Tuleta I, Pizarro C, Kreuter M, Birring SS, Nickenig G, Skowasch D. Association of proangiogenic and profibrotic serum markers with lung function and quality of life in sarcoidosis. PLoS One 2021 Feb;16(2):e0247197.
24. Ulitina AS, Novikova LN, Ilkovich YuM, Baranova OP, Makarova TV, Volkova EV, Pchelina SN, Ilkovich MM, Dubina MV. Influence of AGT, TGFB1, ESR1, and VDR gene variants on development and course of idiopathic interstitial pneumonias and pulmonary sarcoidosis. Pulmonologiya 2017;27(3):346-56 (In Russian).
25. Thillai M, Atkins CP, Crawshaw A, Hart SP, Ho LP, Kouranos V, Patterson K, Screaton NJ, Whight J, Wells AU. BTS Clinical Statement on pulmonary sarcoidosis. Thorax 2021 Jan;76(1):4-20.
26. Viesel AA, Viesel IYu, Shakirova G.R. Evaluation of the efficacy and safety of methotrexate in progressive sarcoidosis: a retrospective observational study. Pulmonologiya 2020;30(2):213-8 (In Russian).
27. Patterson KC, Strek ME. Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Annals of the American Thoracic Society 2013 Aug;10(4):362-70.
28. Tonegawa-Kuji R, Oyama-Manabe N, Aoki R, Nagayoshi S, Pawhay CMH, Kusano K, Nakajima T. T2-weighted short-tau-inversion-recovery imaging reflects disease activity of cardiac sarcoidosis. Open Heart 2021 Sep;8(2):e001728.
29. Walsh SL, Wells AU, Sverzellati N, Keir GJ, Calandriello L, Antoniou KM, Copley SJ, Devaraj A, Maher TM, Renzoni E, Nicholson AG, Hansell DM. An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study. The Lancet. Respiratory Medicine 2014 Feb;2(2):123-30.
30. Shlobin OA, Nathan SD. Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation. The European Respiratory Journal 2012 Jun;39(6):1520-33.
31. Rubio-Rivas M, Corbella X, Mañá J. Elderly sarcoidosis: a comparative study from a 42-year single-centre experience. Respiratory Medicine 2019 Jun;152:1-6.
32. Der Lungenboek im Röntgenbild. Wurm K, Reindell H, Heilmeyer L. Stuttgart: Georg Thieme; 1958. 219 p.
33. Culver DA, Baughman RP. It’s time to evolve from Scadding: phenotyping sarcoidosis. The European Respiratory Journal 2018 Jan;51(1):1800050.
34. Levy A, Hamzeh N, Maier LA. Is it time to scrap Scadding and adopt computed tomography for initial evaluation of sarcoidosis? F1000Research 2018 May 16;7:F1000 Faculty Rev-600. doi: 10.12688/f1000research.11068.1.
35. Nagai S, Nagao T, Hoshino Y, Hamada K. Heterogeneity of pulmonary fibrosis: interstitial pneumonias and sarcoidosis. Current Opinion in Pulmonary Medicine 2001 Sep;7(5):262-71.
36. Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR. American Journal of Roentgenology 2000;174(6):1751-7.
37. Ganeshan D, Menias CO, Lubner MG, Pickhardt PJ, Sandrasegaran K, Bhalla S. Sarcoidosis from head to toe: what the radiologist needs to know. Radiographics 2018;38(4):1180-200.
38. Speranskaya AA, Baranova OP, Vasilyeva MA, Amosov IV. Radiation diagnosis of rare forms of respiratory organ sarcoidosis. Journal of Radiology and Nuclear Medicine 2018;99(4):175-83 (In Russian).
39. Amosov IV, Speranskaya AA, Baranova OP, Yakovleva NS. Radiation diagnostics of fibrosing sarcoidosis of respiratory organs. REJR 2019;9(4):56-67 (In Russian).
40. Collins BF, McClelland RL, Ho LA, Mikacenic CR, Hayes J, Spada C, Raghu G. Sarcoidosis and IPF in the same patient – a coincidence, an association or a phenotype? Respiratory Medicine 2018 Nov;144S:S20-7.
41. Morgenthau AS. Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): genuine disease entity, obscure clinical phenotype or diagnostic red herring? Respiratory Medicine 2018 Nov;144S:S3-4.
42. Collins BF, McClelland RL, Ho LA, Mikacenic CR, Hayes J, Spada C, Raghu G. Sarcoidosis and IPF in the same patient – a coincidence, an association or a phenotype? Respiratory Medicine 2018 Nov;144S:S20-7.
43. Sah BP, Goyal S, Iannuzzi MC. Novel pharmacotherapy of sarcoidosis. Pharmacology & Therapeutics 2016 Jan;157:1-9.
44. Gangemi AJ, Myers CN, Zheng M, Brown J, Butler-LeBair M, Cordova F, Marchetti N, Criner GJ, Gupta R, Mamary AJ. Mortality for sarcoidosis patients on the transplant wait list in the Lung Allocation Score era: experience from a high volume center. Respiratory Medicine 2019 Oct;157:69-76.
45. Richeldi L, Varone F, Bergna M, de Andrade J, Falk J, Hallowell R, Jouneau S, Kondoh Y, Morrow L, Randerath W, Strek M, Tabaj G. Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence. European Respiratory Review 2018 Dec;27(150):180074.
46. Kolaitis NA, Kukreja J, Jones KD, Hays SR, Leard LE. Pirfenidone-induced sarcoid-like reaction: a novel complication. Chest 2018 Oct;154(4):e89-92.
47. Makino S. Progressive fibrosing interstitial lung diseases: a new concept and indication of nintedanib. Modern Rheumatology 2021 Jan;31(1):13-9.
48. Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Nintedanib in progressive fibrosing interstitial lung diseases. The New England Journal of Medicine 2019;381(18):1718-27.
49. Maher T, Langford B, Diamantopoulos A, Rohr K, Baldwin M, Inoue Y. Estimating long-term survival in progressive fibrosing interstitial lung disease (PF-ILD) other than IPF using matched IPF data. The European Respiratory Journal 2021;58(Suppl):65. ID 4238.
50. Płusa T. Postępy w różnicowaniu i leczeniu chorych na sarkoidozę [Advances in differential diagnosis and treatment of patients with sarcoidosis]. Polski Merkuriusz Lekarski 2018 Mar;44(261):135-8. [Article in Polish].
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]